[Advances in vaccines and invasive disease in children].
Moraga Llop
F A
FA
Servicio de Pediatría, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
D000907:Antibodies, Bacterial / Q000096:biosynthesis; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D000075202:Contraindications; D004168:Diphtheria Toxoid / Q000276:immunology; D006192:Haemophilus Infections / Q000453:epidemiology / Q000517:prevention & control; D018073:Haemophilus Vaccines / Q000276:immunology; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007115:Immunization Schedule; D015994:Incidence; D007223:Infant; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000276:immunology; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000276:immunology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012449:Safety; D013030:Spain / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000191:economics / Q000639:trends*; D017778:Vaccines, Combined / Q000276:immunology; D018074:Vaccines, Conjugate / Q000276:immunology
D000907:Antibodies, Bacterial; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines; D017778:Vaccines, Combined; D018074:Vaccines, Conjugate; C410218:serogroup C meningococcal conjugate vaccine